ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Immune Design Corp.

NEW YORK, Feb. 21, 2019 /PRNewswire/ — Rowley Law PLLC is investigating potential claims against Immune Design Corp. (NASDAQ: IMDZ) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Merck Sharp & Dohme Corp. (NYSE: MRK). Stockholders will receive $5.85 for each share of Immune Design Corp. stock that they hold. The transaction is valued at approximately $300 million and is expected to close in the second quarter of 2019. If you are a stockholder of Immune Design Corp. and are interested in obtaining additional information regarding this investigation, please visit us ...

Gepostet in der Kategorie Wirtschaft (Anzahl der ansichten:) 5

Ähnlich Nachrichten